INDEGENE
|
INDEGENE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 16.68 | 16.98 | 15.17 | 12.01 | 938.81 |
| CEPS(Rs) | 21.93 | 20.33 | 18.59 | 14.71 | 8.88 |
| DPS(Rs) | 2.25 | 2.00 | - | - | - |
| Book NAV/Share(Rs) | 128.59 | 107.70 | 62.96 | 47.22 | 4,319.87 |
| Tax Rate(%) | 23.60 | 24.59 | 26.58 | 26.69 | 28.11 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.63 | 18.82 | 19.52 | 17.17 | 17.24 |
| EBIT Margin(%) | 15.50 | 19.77 | 19.62 | 17.10 | 13.96 |
| Pre Tax Margin(%) | 14.96 | 18.99 | 17.71 | 15.74 | 13.61 |
| PAT Margin (%) | 11.43 | 14.32 | 13.00 | 11.54 | 9.78 |
| Cash Profit Margin (%) | 15.03 | 17.15 | 15.94 | 14.13 | 11.79 |
| Performance Ratios | |||||
| ROA(%) | 10.31 | 14.24 | 14.60 | 15.56 | 17.66 |
| ROE(%) | 14.14 | 20.45 | 27.56 | 29.50 | 30.20 |
| ROCE(%) | 18.92 | 25.24 | 30.88 | 35.20 | 41.09 |
| Asset Turnover(x) | 0.90 | 0.99 | 1.12 | 1.35 | 1.81 |
| Sales/Fixed Asset(x) | 2.04 | 2.72 | 2.79 | 4.06 | 7.20 |
| Working Capital/Sales(x) | 2.29 | 1.44 | 2.19 | 2.40 | 2.41 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.49 | 0.37 | 0.36 | 0.25 | 0.14 |
| Receivable days | 90.10 | 89.95 | 90.91 | 85.94 | 79.96 |
| Inventory Days | - | - | - | - | - |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 26.06 | 34.05 | - | - | - |
| PCE(x) | 19.81 | 28.44 | - | - | - |
| Price/Book(x) | 3.38 | 5.37 | - | - | - |
| Yield(%) | 0.52 | 0.35 | - | - | - |
| EV/Net Sales(x) | 2.87 | 4.75 | 0.10 | 0.15 | -0.30 |
| EV/Core EBITDA(x) | 14.57 | 21.00 | 0.44 | 0.78 | -1.59 |
| EV/EBIT(x) | 18.50 | 24.01 | 0.50 | 0.89 | -2.15 |
| EV/CE(x) | 3.21 | 5.15 | 0.14 | 0.24 | -0.64 |
| M Cap / Sales | 2.98 | 4.88 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 23.64 | 9.64 | 12.29 | 38.54 | 72.27 |
| Core EBITDA Growth(%) | 7.72 | 10.28 | 28.10 | 45.17 | 19.77 |
| EBIT Growth(%) | -3.03 | 10.49 | 28.84 | 69.62 | -2.50 |
| PAT Growth(%) | -1.38 | 20.79 | 26.53 | 63.43 | -12.31 |
| EPS Growth(%) | -1.79 | 11.96 | 26.25 | -98.72 | -1.66 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 0.29 | 0.38 | 0.02 |
| Current Ratio(x) | 2.41 | 4.48 | 2.93 | 2.96 | 2.57 |
| Quick Ratio(x) | 2.41 | 4.48 | 2.93 | 2.96 | 2.57 |
| Interest Cover(x) | 28.20 | 25.51 | 10.28 | 12.60 | 38.98 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹13,347.1 Cr | 5.8% | 12.1% | -0.5% | Stock Analytics | |
| PRIME FOCUS | ₹23,519.9 Cr | -1.9% | 29.5% | 114.2% | Stock Analytics | |
| SAGILITY | ₹20,640.0 Cr | -1.7% | 8.7% | 4.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,441.4 Cr | -1.5% | -5.4% | -41.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,514.5 Cr | 3.5% | 0.8% | -8.7% | Stock Analytics | |
| NESCO | ₹7,393.7 Cr | -3.7% | -8.8% | -12.9% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 5.8% |
12.1% |
-0.5% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses
